Background
According to Statista, China has already surpassed the US and become the largest OTC pharmaceutical market in the world. The OTC drug revenue in China is expected to be the US $27.28bn in 2022.
To enter such a market via general trade, OTC drugs usually need to go through complicated marketing authorization procedures that may last 2-3 years if exempted from clinical trials, or even 4-5 years if subject to clinical trials.
Thus, cross-border e-commerce is developing as a promising approach to China\’s OTC pharmaceutical market. In Statista\’s estimation, 57.9% of total revenue will be generated through online sales in China\’s OTC pharmaceutical market in 2022.